FDA inspection News
Most Popular FDA inspection Story
FDA: Novartis plant shows patterns of problems
Health Canada on Friday advised Canadians that they should return certain Excedrin Extra Strength and Tension Headache caplets, just as drug giant Novartis ($NVS) advised U.S. consumers to do last Read more...
Latest Headlines
- January 19, 2012
- January 16, 2012
- December 14, 2011
- November 21, 2011
- November 14, 2011
- November 8, 2011
- October 19, 2011
- August 26, 2011
- August 15, 2011
- February 14, 2011
- November 29, 2010
- September 29, 2010
- March 17, 2010
- September 8, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
